BiologicalDrug
Bone Marrow-Derived Mononuclear Cells clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
4 studies that test it; most in 2008 (3)
| Year | Studies |
|---|---|
| 2008 | 3 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 4
Royan Institute (2) · Fuzhou General Hospital (1) · Van Hanh General Hospital (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Bone Marrow-Derived Mononuclear Cells is read from its arms, and is right about nine times in ten.
Testing it · 4
- BM-MNCs and UC-MSCs Infusion for Type 2 Diabetes Mellitus PatientsStatus unknownPhase 1/2Van Hanh General HospitalNCT03943940Written as BM-MNC and UC-MSC
- Bone Marrow Mononuclear Cell and Hyperbaric Oxygen Therapy in Diabetes MellitusCompletedPhase 1/2Fuzhou General HospitalNCT00767260Written as BM-MNC
- Autologous Bone Marrow Stem Cells in Cirrhosis PatientsCompletedPhase 1/2Royan InstituteNCT00713934Written as BM-MNC
- Autologous Transplantation of Bone Marrow Mononuclear Cell (BM-MNC) With and Without Granulocyte-Colony Stimulation Factor (G-CSF) for Treatment of Chronic Lower Limb Ischemic PatientsCompletedPhase 1/2Royan InstituteNCT00677404Written as BM-MNC injection